- Home
- TMDX vs GATX Comparison
TMDX vs GATX Comparison
Compare TMDX & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- GATX
- Stock Information
- Founded
- TMDX 1998
- GATX 1898
- Country
- TMDX United States
- GATX United States
- Employees
- TMDX N/A
- GATX N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GATX Transportation Services
- Sector
- TMDX Health Care
- GATX Consumer Discretionary
- Exchange
- TMDX Nasdaq
- GATX Nasdaq
- Market Cap
- TMDX 4.8B
- GATX 5.5B
- IPO Year
- TMDX 2019
- GATX N/A
- Fundamental
- Price
- TMDX $122.68
- GATX $159.71
- Analyst Decision
- TMDX Buy
- GATX Buy
- Analyst Count
- TMDX 9
- GATX 2
- Target Price
- TMDX $123.00
- GATX $172.50
- AVG Volume (30 Days)
- TMDX 1.3M
- GATX 170.5K
- Earning Date
- TMDX 07-30-2025
- GATX 07-29-2025
- Dividend Yield
- TMDX N/A
- GATX 1.54%
- EPS Growth
- TMDX 2163.11
- GATX 34.45
- EPS
- TMDX 2.02
- GATX 8.74
- Revenue
- TMDX $531,292,000.00
- GATX $1,671,000,000.00
- Revenue This Year
- TMDX $34.57
- GATX $10.94
- Revenue Next Year
- TMDX $20.83
- GATX $5.40
- P/E Ratio
- TMDX $61.12
- GATX $18.09
- Revenue Growth
- TMDX 48.09
- GATX 11.74
- 52 Week Low
- TMDX $55.00
- GATX $127.70
- 52 Week High
- TMDX $177.37
- GATX $168.89
- Technical
- Relative Strength Index (RSI)
- TMDX 51.30
- GATX 58.29
- Support Level
- TMDX $114.30
- GATX $154.87
- Resistance Level
- TMDX $133.54
- GATX $161.24
- Average True Range (ATR)
- TMDX 6.78
- GATX 2.76
- MACD
- TMDX 0.98
- GATX 0.73
- Stochastic Oscillator
- TMDX 51.17
- GATX 76.00
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.